Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Absci (ABSI) Change in Accured Expenses (2020 - 2025)

Absci (ABSI) posted Change in Accured Expenses of $2.5 million for Q3 2025, up 22.87% sequentially from $2.0 million in Q2 2025, and up 80.22% YoY from $1.4 million in Q3 2024.

Analysis

Absci (ABSI) Change in Accured Expenses (2020 - 2025) Analysis & Trends

Absci has reported Change in Accured Expenses for 6 years, with the latest figure at $2.5 million in Q3 2025.

  • Quarterly Change in Accured Expenses rose 80.22% year-over-year to $2.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.9 million (up 233.87% YoY) and the FY2024 annual result came in at -$295000.0, up 75.68% from the prior year.
  • Change in Accured Expenses improved to $2.5 million in Q3 2025 per ABSI's latest filing, from $2.0 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $3.9 million in Q3 2022 and troughed at -$4.5 million in Q1 2022.
  • A 5-year average of -$77947.4 and a median of -$374000.0 in 2023 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2021 and 2022: Change in Accured Expenses slumped 1337.23% in 2021, then surged 437.49% in 2022.
  • Over 5 years, Change in Accured Expenses stood at $2.1 million in 2021, then slumped by 123.28% to -$500000.0 in 2022, then increased by 25.2% to -$374000.0 in 2023, then soared by 303.21% to $760000.0 in 2024, then jumped by 230.79% to $2.5 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered $2.5 million, $2.0 million, and -$3.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Absci 1.39 Bn 1.19 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.51 Mn
Jun 30, 2025 2.05 Mn
Mar 31, 2025 -3.41 Mn
Dec 31, 2024 760,000.00
Sep 30, 2024 1.40 Mn
Jun 30, 2024 1.46 Mn
Mar 31, 2024 -3.91 Mn
Dec 31, 2023 -374,000.00
Sep 30, 2023 2.96 Mn
Jun 30, 2023 -1.38 Mn
Mar 31, 2023 -2.43 Mn
Dec 31, 2022 -500,000.00
Sep 30, 2022 3.93 Mn
Jun 30, 2022 -601,000.00
Mar 31, 2022 -4.53 Mn
Dec 31, 2021 2.15 Mn
Sep 30, 2021 -1.16 Mn
Jun 30, 2021 -848,000.00
Mar 31, 2021 444,000.00
Dec 31, 2020 1.01 Mn